Cooper EPS - Earnings per Share 2010-2024 | COO

Cooper annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Cooper EPS for the quarter ending January 31, 2024 was $0.41, a 4.65% decline year-over-year.
  • Cooper EPS for the twelve months ending January 31, 2024 was $1.46, a 22.98% decline year-over-year.
  • Cooper 2023 annual EPS was $1.48, a 23.81% decline from 2022.
  • Cooper 2022 annual EPS was $1.94, a 86.88% decline from 2021.
  • Cooper 2021 annual EPS was $14.79, a 1129.43% increase from 2020.
Cooper Annual EPS
2023 $1.48
2022 $1.94
2021 $14.79
2020 $1.20
2019 $2.33
2018 $0.70
2017 $1.88
2016 $1.40
2015 $1.04
2014 $1.38
2013 $1.49
2012 $1.26
2011 $0.91
2010 $0.61
2009 $0.55
Cooper Quarterly EPS
2024-01-31 $0.41
2023-10-31 $0.42
2023-07-31 $0.43
2023-04-30 $0.20
2023-01-31 $0.43
2022-10-31 $0.33
2022-07-31 $0.50
2022-04-30 $0.64
2022-01-31 $0.48
2021-10-31 $0.53
2021-07-31 $3.09
2021-04-30 $0.59
2021-01-31 $10.58
2020-10-31 $0.41
2020-07-31 $0.28
2020-04-30 $0.06
2020-01-31 $0.46
2019-10-31 $0.60
2019-07-31 $0.60
2019-04-30 $0.61
2019-01-31 $0.52
2018-10-31 $0.51
2018-07-31 $0.51
2018-04-30 $0.31
2018-01-31 $-0.63
2017-10-31 $0.45
2017-07-31 $0.52
2017-04-30 $0.53
2017-01-31 $0.38
2016-10-31 $0.31
2016-07-31 $0.45
2016-04-30 $0.38
2016-01-31 $0.26
2015-10-31 $0.19
2015-07-31 $0.23
2015-04-30 $0.31
2015-01-31 $0.31
2014-10-31 $0.16
2014-07-31 $0.45
2014-04-30 $0.41
2014-01-31 $0.37
2013-10-31 $0.29
2013-07-31 $0.45
2013-04-30 $0.38
2013-01-31 $0.38
2012-10-31 $0.36
2012-07-31 $0.34
2012-04-30 $0.28
2012-01-31 $0.28
2011-10-31 $0.29
2011-07-31 $0.23
2011-04-30 $0.18
2011-01-31 $0.21
2010-10-31 $0.26
2010-07-31 $0.22
2010-04-30 $0.03
2010-01-31 $0.11
2009-10-31 $0.17
2009-07-31 $0.12
2009-04-30 $0.14
2009-01-31 $0.13
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.222B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.909B 18.71
Becton Dickinson (BDX) United States $67.707B 19.66
West Pharmaceutical Services (WST) United States $28.565B 48.29
Cardinal Health (CAH) United States $25.143B 15.11
Align Technology (ALGN) United States $23.470B 47.33
Labcorp (LH) United States $17.496B 14.94
Henry Schein (HSIC) United States $9.348B 16.17
DENTSPLY SIRONA (XRAY) United States $6.399B 16.86
Merit Medical Systems (MMSI) United States $4.307B 24.65
STAAR Surgical (STAA) United States $2.355B 74.14
Patterson (PDCO) United States $2.327B 11.15
CONMED (CNMD) United States $2.196B 20.67
Atrion (ATRI) United States $0.713B 36.74
Lifevantage (LFVN) United States $0.082B 13.34
Pro-Dex (PDEX) United States $0.066B 25.00
Biolase (BIOL) United States $0.005B 0.00